The London Joint Working Group on Substance Use and Hepatitis C
LJWG was formed in 2009 to help drive improvements in the prevention, diagnosis and treatment of hepatitis C in people who use drugs in London.
We work together to improve outcomes for people with hepatitis C in this vulnerable population. The LJWG collaborates with stakeholders from the health service, providers, policy makers, pharmaceutical companies and service users.
THE LJWG 2022 ANNUAL CONFERENCE
The London Joint Working Group on Substance Use and Hepatitis C held our 2022 annual conference on Thursday June 16th 2022, bringing together professionals working in hepatitis C care in London. You can now watch the talks and panels on our YouTube channel. Speakers included:
- Dr Tom Coffey OBE – Health Advisor, Mayor of London
- Rachel Halford – The Hepatitis C Trust
- Dr Monica Desai – UK Health Security Agency
- Professor Graham Foster – NHS England
- Professor Geoffrey Dusheiko, Consultant Hepatologist at King’s College Hospital
What we do
We run pilot projects to improve hepatitis C diagnosis, care and treatment across London.
We produce reports to help people understand the wider challenges
and overcome barriers to addressing hepatitis C.
We create well-researched and tested resources for substance misuse services and people at risk of hepatitis C.